US Stock MarketDetailed Quotes

AVTX Avalo Therapeutics

Watchlist
  • 13.0100
  • +0.4300+3.42%
Close Oct 31 16:00 ET
  • 12.7500
  • -0.2600-2.00%
Post 19:04 ET
126.20MMarket Cap0.07P/E (TTM)

Avalo Therapeutics Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Total revenue
0
0
-89.34%1.92M
-36.27%571K
-98.42%236K
-37.75%643K
-59.51%475K
234.40%18.05M
309.13%896K
1,007.33%14.95M
Operating revenue
--0
--0
-89.34%1.92M
-36.27%571K
-98.42%236K
-37.75%643K
-59.51%475K
234.40%18.05M
309.13%896K
1,007.33%14.95M
Cost of revenue
-51.55%343K
-114.52%-80K
-62.61%1.28M
-135.65%-221K
-53.22%247K
-54.82%708K
-23.47%551K
130.32%3.43M
46.23%620K
-41.85%528K
Gross profit
-427.69%-343K
205.26%80K
-95.62%640K
186.96%792K
-100.08%-11K
87.83%-65K
-116.78%-76K
274.12%14.62M
234.63%276K
3,162.67%14.42M
Operating expense
28.85%9.13M
-39.09%5.31M
-53.74%24.08M
-50.25%4.54M
-63.79%3.74M
-37.27%7.09M
-59.09%8.72M
-39.50%52.06M
-48.58%9.13M
-38.92%10.33M
Selling and administrative expenses
86.57%4.53M
17.91%3.19M
-50.27%10.3M
-9.56%2.68M
-24.18%2.49M
-12.82%2.43M
-76.82%2.71M
-16.01%20.71M
-50.53%2.96M
-44.58%3.28M
-Selling and marketing expense
200.00%21K
-46.15%7K
-56.58%33K
-41.67%7K
16.67%7K
-50.00%7K
-69.77%13K
-95.41%76K
-98.04%12K
-98.76%6K
-General and administrative expense
86.24%4.51M
18.22%3.19M
-50.24%10.27M
-9.43%2.67M
-24.25%2.48M
-12.64%2.42M
-76.85%2.7M
-10.29%20.64M
-45.10%2.95M
-39.79%3.28M
Research and development costs
-1.22%4.6M
-64.78%2.12M
-55.97%13.78M
-69.75%1.87M
-82.26%1.25M
-45.26%4.66M
-37.31%6.01M
-47.68%31.31M
-46.38%6.17M
-33.26%7.04M
Depreciation amortization depletion
----
----
--0
--0
--0
----
----
-97.55%38K
--0
--0
-Depreciation and amortization
----
----
--0
--0
--0
----
----
-97.55%38K
--0
--0
Operating profit
-32.48%-9.47M
40.53%-5.23M
37.38%-23.44M
57.64%-3.75M
-191.58%-3.75M
39.55%-7.15M
57.84%-8.79M
54.42%-37.44M
50.70%-8.86M
124.87%4.1M
Net non-operating interest income expense
204.32%1.04M
110.54%100K
18.06%-3.42M
108.54%81K
-72.94%-1.55M
13.69%-996K
18.82%-949K
-74.40%-4.17M
19.85%-949K
8.83%-898K
Non-operating interest income
----
--100K
----
----
----
----
----
----
----
----
Non-operating interest expense
----
----
-18.06%3.42M
-108.54%-81K
72.94%1.55M
----
-18.82%949K
74.40%4.17M
-19.85%949K
-8.83%898K
Total other finance cost
-204.32%-1.04M
----
----
----
----
--996K
----
----
----
----
Other net income (expense)
267,357.50%106.9M
-56,285.44%-116.15M
-23,245.00%-4.67M
-4.51M
83K
-40K
-930.00%-206K
0.00%-20K
0
Gain on sale of security
267,615.00%107.01M
-44,008.89%-79.4M
---720K
---600K
--100K
---40K
---180K
----
----
----
Special income (charges)
---103K
---36.76M
---3.91M
----
----
--0
--0
--0
----
----
-Less:Restructuring and merger&acquisition
--0
--9.22M
----
----
----
--0
--0
----
----
----
-Less:Impairment of capital assets
----
----
--3.91M
----
----
----
----
--0
----
----
-Less:Other special charges
--103K
--27.54M
----
----
----
----
----
----
----
----
Other non- operating income (expenses)
----
----
-110.00%-42K
--0
---17K
----
-30.00%-26K
0.00%-20K
--0
----
Income before tax
1,302.91%98.47M
-1,119.29%-121.28M
24.26%-31.53M
16.60%-8.18M
-263.28%-5.22M
36.94%-8.19M
54.87%-9.95M
50.76%-41.63M
48.80%-9.8M
118.31%3.2M
Income tax
0.00%7K
-12.50%7K
-50.00%14K
-212.50%-9K
60.00%8K
40.00%7K
-11.11%8K
114.29%28K
150.00%8K
-37.50%5K
Net income
1,301.79%98.46M
-1,118.38%-121.29M
24.28%-31.54M
16.75%-8.17M
-263.78%-5.23M
36.91%-8.19M
54.85%-9.96M
50.63%-41.66M
48.89%-9.81M
118.35%3.19M
Net income continuous Operations
1,301.79%98.46M
-1,118.38%-121.29M
24.28%-31.54M
16.75%-8.17M
-263.78%-5.23M
36.91%-8.19M
54.85%-9.96M
50.61%-41.66M
48.71%-9.81M
118.27%3.19M
Minority interest income
Net income attributable to the parent company
1,301.79%98.46M
-1,118.38%-121.29M
24.28%-31.54M
16.75%-8.17M
-263.78%-5.23M
36.91%-8.19M
54.85%-9.96M
50.63%-41.66M
48.89%-9.81M
118.35%3.19M
Preferred stock dividends
Other preferred stock dividends
94.11M
Net income attributable to common stockholders
153.14%4.35M
-1,118.38%-121.29M
24.28%-31.54M
16.75%-8.17M
-263.78%-5.23M
36.91%-8.19M
54.85%-9.96M
50.63%-41.66M
48.89%-9.81M
118.35%3.19M
Basic earnings per share
817.97%1.01K
30.88%-141
89.28%-114
95.92%-10.1878
-132.35%-26.4
57.51%-140.73
63.83%-204
55.49%-1.06K
46.16%-249.4
116.35%81.6
Diluted earnings per share
-2,299.49%-3.38K
30.88%-141
89.28%-114
95.92%-10.1878
-132.35%-26.4
57.51%-140.73
63.83%-204
55.49%-1.06K
46.16%-249.4
116.35%81.6
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Total revenue 00-89.34%1.92M-36.27%571K-98.42%236K-37.75%643K-59.51%475K234.40%18.05M309.13%896K1,007.33%14.95M
Operating revenue --0--0-89.34%1.92M-36.27%571K-98.42%236K-37.75%643K-59.51%475K234.40%18.05M309.13%896K1,007.33%14.95M
Cost of revenue -51.55%343K-114.52%-80K-62.61%1.28M-135.65%-221K-53.22%247K-54.82%708K-23.47%551K130.32%3.43M46.23%620K-41.85%528K
Gross profit -427.69%-343K205.26%80K-95.62%640K186.96%792K-100.08%-11K87.83%-65K-116.78%-76K274.12%14.62M234.63%276K3,162.67%14.42M
Operating expense 28.85%9.13M-39.09%5.31M-53.74%24.08M-50.25%4.54M-63.79%3.74M-37.27%7.09M-59.09%8.72M-39.50%52.06M-48.58%9.13M-38.92%10.33M
Selling and administrative expenses 86.57%4.53M17.91%3.19M-50.27%10.3M-9.56%2.68M-24.18%2.49M-12.82%2.43M-76.82%2.71M-16.01%20.71M-50.53%2.96M-44.58%3.28M
-Selling and marketing expense 200.00%21K-46.15%7K-56.58%33K-41.67%7K16.67%7K-50.00%7K-69.77%13K-95.41%76K-98.04%12K-98.76%6K
-General and administrative expense 86.24%4.51M18.22%3.19M-50.24%10.27M-9.43%2.67M-24.25%2.48M-12.64%2.42M-76.85%2.7M-10.29%20.64M-45.10%2.95M-39.79%3.28M
Research and development costs -1.22%4.6M-64.78%2.12M-55.97%13.78M-69.75%1.87M-82.26%1.25M-45.26%4.66M-37.31%6.01M-47.68%31.31M-46.38%6.17M-33.26%7.04M
Depreciation amortization depletion ----------0--0--0---------97.55%38K--0--0
-Depreciation and amortization ----------0--0--0---------97.55%38K--0--0
Operating profit -32.48%-9.47M40.53%-5.23M37.38%-23.44M57.64%-3.75M-191.58%-3.75M39.55%-7.15M57.84%-8.79M54.42%-37.44M50.70%-8.86M124.87%4.1M
Net non-operating interest income expense 204.32%1.04M110.54%100K18.06%-3.42M108.54%81K-72.94%-1.55M13.69%-996K18.82%-949K-74.40%-4.17M19.85%-949K8.83%-898K
Non-operating interest income ------100K--------------------------------
Non-operating interest expense ---------18.06%3.42M-108.54%-81K72.94%1.55M-----18.82%949K74.40%4.17M-19.85%949K-8.83%898K
Total other finance cost -204.32%-1.04M------------------996K----------------
Other net income (expense) 267,357.50%106.9M-56,285.44%-116.15M-23,245.00%-4.67M-4.51M83K-40K-930.00%-206K0.00%-20K0
Gain on sale of security 267,615.00%107.01M-44,008.89%-79.4M---720K---600K--100K---40K---180K------------
Special income (charges) ---103K---36.76M---3.91M----------0--0--0--------
-Less:Restructuring and merger&acquisition --0--9.22M--------------0--0------------
-Less:Impairment of capital assets ----------3.91M------------------0--------
-Less:Other special charges --103K--27.54M--------------------------------
Other non- operating income (expenses) ---------110.00%-42K--0---17K-----30.00%-26K0.00%-20K--0----
Income before tax 1,302.91%98.47M-1,119.29%-121.28M24.26%-31.53M16.60%-8.18M-263.28%-5.22M36.94%-8.19M54.87%-9.95M50.76%-41.63M48.80%-9.8M118.31%3.2M
Income tax 0.00%7K-12.50%7K-50.00%14K-212.50%-9K60.00%8K40.00%7K-11.11%8K114.29%28K150.00%8K-37.50%5K
Net income 1,301.79%98.46M-1,118.38%-121.29M24.28%-31.54M16.75%-8.17M-263.78%-5.23M36.91%-8.19M54.85%-9.96M50.63%-41.66M48.89%-9.81M118.35%3.19M
Net income continuous Operations 1,301.79%98.46M-1,118.38%-121.29M24.28%-31.54M16.75%-8.17M-263.78%-5.23M36.91%-8.19M54.85%-9.96M50.61%-41.66M48.71%-9.81M118.27%3.19M
Minority interest income
Net income attributable to the parent company 1,301.79%98.46M-1,118.38%-121.29M24.28%-31.54M16.75%-8.17M-263.78%-5.23M36.91%-8.19M54.85%-9.96M50.63%-41.66M48.89%-9.81M118.35%3.19M
Preferred stock dividends
Other preferred stock dividends 94.11M
Net income attributable to common stockholders 153.14%4.35M-1,118.38%-121.29M24.28%-31.54M16.75%-8.17M-263.78%-5.23M36.91%-8.19M54.85%-9.96M50.63%-41.66M48.89%-9.81M118.35%3.19M
Basic earnings per share 817.97%1.01K30.88%-14189.28%-11495.92%-10.1878-132.35%-26.457.51%-140.7363.83%-20455.49%-1.06K46.16%-249.4116.35%81.6
Diluted earnings per share -2,299.49%-3.38K30.88%-14189.28%-11495.92%-10.1878-132.35%-26.457.51%-140.7363.83%-20455.49%-1.06K46.16%-249.4116.35%81.6
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes----

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data